1AI 0.00% 0.9¢ algorae pharmaceuticals limited

Ann: NTCELL Parkinsons trial 2 year data analysis shows success, page-63

  1. 704 Posts.
    lightbulb Created with Sketch. 71
    Hi Osgood
    I recall 5 points per year so 2 per six months not too diff. my interpretation, and again this could all be clarified if LCT considered the non-scientific conglomerate that follow them, is that the baseline (0) is the baseline from when the trails where started and that no deterioration has been factored in or shown on this chart. which would be really good to see one line deteriorating, by now it would be 0-10 from 0-104 weeks and would show the benefit of NTCell
    this assumption could be very wrong though by me
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $15.18M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
5 2463308 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 274836 3
View Market Depth
Last trade - 16.12pm 10/07/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.